download PDF - Newron

To the best of Newron’s knowledge, the following shareholders had holdings of more than
3% of the equity capital or voting rights of Newron as at December 31, 2011. The number of
shares shown as well as the holding percentages are based on the last disclosure of shareholding
received from the shareholder. Please be aware that since then, the information could have
become outdated because of changes that did not trigger notifications:
Shareholder Note Holding at Dec. 31, 2011
Shares
% of share capital
Great Point Partners 1 660,395 9.1%
3i Group plc 2 539,937 7.4%
NWB Investissements S.p.r.l.* 2 410,900 5.7%
TVM Life Science Ventures VI GmbH & Co. KG 2 274,062 3.8%
Orbimed 3 243,000 3.3%
Aviva Investors 2 235,000 3.2%
1 As per disclosure of shareholding published Jan. 13, 2011
2 No disclosure in 2011
3 As per registration to 2011 EGM
Link to access individual significant shareholders’ reports:
http://www.six-swiss-exchange.com/shares/companies/major_shareholders_de.html
* Indirectly controlled by Apax France VI
726,435 new shares have been subscribed in a transaction announced by the Company as of
April 5, 2012, by Zambon Company S.p.A. (for details, see page 18).
Cross-shareholdings
As of December 31, 2011, there are no cross-shareholdings in excess of 5% of capital or voting
rights with any other company.
Group Structure and Shareholders – Newron Annual Report 2011 15